Tango Therapeutics
The Senior Biostatistician will serve as the statistical expert for Tango Therapeutics' oncology clinical programs, collaborating with cross‑functional teams and CROs to design trials, develop analysis plans, and oversee statistical deliverables for regulatory submissions. The role involves strategic input on trial design, quality assurance of statistical outputs, and contribution to publications and regulatory interactions.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
50% above the average for this role
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Senior Biostatistician
Structure Therapeutics
Principal Biostatistician
Entrada Therapeutics
Principal Biostatistician Consultant- Remote in US (Oncology)
ClinChoice
Principal Biostatistician Consultant_Oncology_ Remote in US
ClinChoice
Sr. Biostatistician
Therapeutics, Inc.
Senior Biostatistician
Integrated Resources INC